Asia Pacific — Net Sales
Stryker Asia Pacific — Net Sales remained flat by 0.0% to $541M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 7.1%, from $505M to $541M. Over 4 years (FY 2021 to FY 2025), Asia Pacific — Net Sales shows relatively stable performance with a 2.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates growing market share or higher demand for the company's medical products in the region, while a decrease may signal competitive pressure or economic headwinds.
Detailed definition
This metric represents the total revenue generated from the sale of medical devices, equipment, and services within the...
Peer comparison
Comparable to regional revenue reporting by other multinational medical device manufacturers, often benchmarked against regional GDP growth and healthcare spending trends.
syk_segment_asia_pacific_net_salesHistorical Data
| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $1.97B | $1.89B | $1.95B | $2.02B | $2.16B |
| YoY Change | — | -4.5% | +3.2% | +3.8% | +7.1% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Stryker's asia pacific — net sales?
- Stryker (SYK) reported asia pacific — net sales of $541M in Q4 2025.
- How has Stryker's asia pacific — net sales changed year-over-year?
- Stryker's asia pacific — net sales increased by 7.1% year-over-year, from $505M to $541M.
- What is the long-term trend for Stryker's asia pacific — net sales?
- Over 4 years (2021 to 2025), Stryker's asia pacific — net sales has grown at a 2.3% compound annual growth rate (CAGR), from $1.97B to $2.16B.
- What does asia pacific — net sales mean?
- The total revenue earned from customers located in the Asia Pacific region.